These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma]. Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294 [No Abstract] [Full Text] [Related]
25. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin? Gao FF; Bhargava R; Yang H; Li Z; Zhao C Hum Pathol; 2013 Aug; 44(8):1534-43. PubMed ID: 23465279 [TBL] [Abstract][Full Text] [Related]
26. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. Kuhn E; Kurman RJ; Vang R; Sehdev AS; Han G; Soslow R; Wang TL; Shih IeM J Pathol; 2012 Feb; 226(3):421-6. PubMed ID: 21990067 [TBL] [Abstract][Full Text] [Related]
27. Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship. Ardighieri L; Mori L; Conzadori S; Bugatti M; Falchetti M; Donzelli CM; Ravaggi A; Odicino FE; Facchetti F Virchows Arch; 2016 Jul; 469(1):61-9. PubMed ID: 27059324 [TBL] [Abstract][Full Text] [Related]
28. The emerging role of the distal Fallopian tube and p53 in pelvic serous carcinogenesis. Herrington CS; McCluggage WG J Pathol; 2010 Jan; 220(1):5-6. PubMed ID: 19882674 [TBL] [Abstract][Full Text] [Related]
29. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases. Maeda D; Ota S; Takazawa Y; Ohashi K; Mori M; Imamura T; Nakagawa S; Yano T; Taketani Y; Fukayama M Virchows Arch; 2010 Nov; 457(5):597-608. PubMed ID: 20872013 [TBL] [Abstract][Full Text] [Related]
30. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Roh MH; Yassin Y; Miron A; Mehra KK; Mehrad M; Monte NM; Mutter GL; Nucci MR; Ning G; Mckeon FD; Hirsch MS; Wa X; Crum CP Mod Pathol; 2010 Oct; 23(10):1316-24. PubMed ID: 20562848 [TBL] [Abstract][Full Text] [Related]
31. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma. Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278 [TBL] [Abstract][Full Text] [Related]
32. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
33. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma. Soong TR; Howitt BE; Horowitz N; Nucci MR; Crum CP Gynecol Oncol; 2019 Feb; 152(2):426-433. PubMed ID: 30503267 [TBL] [Abstract][Full Text] [Related]
34. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Ortiz BH; Ailawadi M; Colitti C; Muto MG; Deavers M; Silva EG; Berkowitz RS; Mok SC; Gershenson DM Cancer Res; 2001 Oct; 61(19):7264-7. PubMed ID: 11585764 [TBL] [Abstract][Full Text] [Related]
35. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer). Seidman JD Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178 [TBL] [Abstract][Full Text] [Related]
36. Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma. Jia L; Yuan Z; Wang Y; Cragun JM; Kong B; Zheng W Mod Pathol; 2015 Jan; 28(1):118-27. PubMed ID: 24925054 [TBL] [Abstract][Full Text] [Related]
37. A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers. Cass I; Walts AE; Barbuto D; Lester J; Karlan B Gynecol Oncol; 2014 Sep; 134(3):492-7. PubMed ID: 25026639 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the fallopian tubes after neoadjuvant chemotherapy: persistence of serous tubal intraepithelial carcinoma. Colón E; Carlson JW Int J Gynecol Pathol; 2014 Sep; 33(5):463-9. PubMed ID: 25083961 [TBL] [Abstract][Full Text] [Related]
39. The presence of mucosal iron in the fallopian tube supports the "incessant menstruation hypothesis" for ovarian carcinoma. Seidman JD Int J Gynecol Pathol; 2013 Sep; 32(5):454-8. PubMed ID: 23896711 [TBL] [Abstract][Full Text] [Related]
40. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series. Morrison JC; Blanco LZ; Vang R; Ronnett BM Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]